The copper (Cu)-exporter ATP7A is upregulated at the KRAS-mutated cells' surface and protects these cells from cuproptosis, indicating a KRAS-selective vulnerability based on the copper bioavailability in CRC 47. The gene discussed is KRAS; the disease is colorectal carcinoma.